REAL-WORLD EVIDENCE IN THE CONTEXT OF HTA: ON THE EXAMPLE OF UTERINE FIBROIDS TREATMENT IN UKRAINE

被引：0
|
作者：
Piniazhko, O. [1 ]
Zaliska, O. [1 ]
机构：
[1] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.08.178
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIH7
引用
收藏
页码：A904 / A904
页数：1
相关论文
共 50 条
  • [31] Systematic Review of Real-World Evidence on Treatment of Acromegaly
    Nellesen, Dave
    Hong Truong
    Oh, Debora
    Neary, Maureen P.
    Ludlam, William H.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [32] A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China
    Li, Dan
    Yin, Na
    Du, Guobo
    Wang, Shaohua
    Xiao, Zhibo
    Chen, Jinyun
    Chen, Wenzhi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (03): : 388 - 395
  • [33] Is Real-world Evidence Really Real?
    Kristensen, Lars Erik
    Egeberg, Alexander
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (02) : 126 - 127
  • [34] Real-world evidence in the context of molar incisor hypomineralization: A new perspective
    Santos-Pinto, Lourdes
    Bullio Fragelli, Camila Maria
    Bussaneli, Diego Girotto
    Restrepo, Manuel
    Costa Nogueira, Vinicius Krieger
    de Farias, Aline Leite
    Yupanqui, Kasandra Veronica
    Benini Paschoal, Marco Aurelio
    Cordeiro, Rita
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2021, 31 (04) : 483 - 485
  • [35] "Real-World Evidence?" Get Real!
    King, Spencer B., III
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (02) : 204 - 205
  • [36] Real-World Evidence in the Real World: Beyond the FDA
    Krause, Joan H.
    Saver, Richard S.
    AMERICAN JOURNAL OF LAW & MEDICINE, 2018, 44 (2-3) : 161 - 179
  • [37] IMPACT OF REAL-WORLD EVIDENCE IN THE HTA PROCESS IN FRANCE: ANALYSIS OF TRANSPARENCY COMMISSION APPRAISALS IN RARE DISEASES
    Akhamlich, I
    Lefevre, C.
    Schmidely, N.
    Vega, Ramirez C.
    Marquet, T.
    VALUE IN HEALTH, 2024, 27 (12) : S371 - S371
  • [38] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS IN HTA PRE- AND POSTINTRODUCTION OF THE NICE FRAMEWORK
    Mackley, R.
    Green, R.
    Shrivastava, M.
    Chasimpha, S.
    Teague, R.
    VALUE IN HEALTH, 2023, 26 (12) : S390 - S391
  • [39] COMBINING CLINICAL TRIAL AND REAL-WORLD EVIDENCE DATA IN THE ASSESSMENT OF PUBLIC HEALTH IMPACT IN HTA EVALUATIONS
    Leleu, H.
    Nucit, A.
    Lefevre, C.
    Salvignol, O.
    Grenier, B.
    Coulibaly, C.
    Jolivel, R.
    Blachier, M.
    VALUE IN HEALTH, 2022, 25 (01) : S198 - S198
  • [40] DOES REAL-WORLD EVIDENCE PLAY A ROLE IN DECISION-MAKING BY HTA BODIES FOR MEDICAL TECHNOLOGIES?
    Hartley, L.
    Gildea, L.
    Mordin, M.
    Long, J.
    D'Souza, V
    Kinderas, M.
    Ling, C.
    Warttig, S.
    VALUE IN HEALTH, 2023, 26 (12) : S434 - S435
12345